蛋白質工程實驗室自動化市場——增長、趨勢、COVID-19 影響和預測 (2023-2028)

蛋白質工程實驗室自動化市場預計在預測期內（2022-2027 年）以 12.4% 的複合年增長率增長。

蛋白質工程的自動化可以幫助科學家破譯和解決蛋白質錯誤行為的奧秘，例如錯誤折疊、聚集和異常運動。 結果是更有效的藥物發現。 蛋白質工程行業自動化的主要驅動力之一是對蛋白質藥物的需求超過非蛋白質藥物的快速增長以及生活方式疾病的日益流行。

主要亮點

• 蛋白質和能量營養不良 (PEM) 在新興國家/地區的農村地區日益嚴重。 指的是一組疾病，包括誇希奧科爾症、消瘦症和誇希奧科爾氏症過渡期消瘦症。 因此，kwashiorkor 的發病率因地區而異。 在美國很少見。 拉丁美洲、東南亞、剛果、牙買加、波多黎各和南非受到影響。 因此，蛋白質缺乏症的發生頻率不斷增加，正在推高整體市場需求。
• 醫療保健業務受到政府舉措增加的影響，包括蛋白質工程的研發和宣傳計劃的讚助。 因此，政府搶先資助了幾項研究計劃。 例如，Protein Technologies Ltd (PTL) 已獲得英國政府技術戰略委員會（現為 Innovate UK）的資助，用於開創性的蛋白質工程研究。
• 蛋白質工程在農化業務領域也具有巨大潛力，因為它可以改善□的功能、提高作物產量並促進生物燃料的生產。 作為實現未來農業高產所需的技術，它也有望發揮重要作用。
• 自 COVID-19 爆發以來，實驗室已將其場地和資源轉變為 COVID-19 檢測設施，並增加了自動化設備的使用。 華盛頓大學的一個實驗室就是第一個例子。 在 Broad Institute 宣布將其臨床處理實驗室轉變為大型 COVID-19 測試設施之後，他發表了上述言論。

蛋白質工程實驗室自動化市場趨勢

自動液體處理設備佔有最大市場份額

• 液體處理器通常用於生物化學和化學實驗室。 自動液體處理機器人有助於在實驗室中分配樣品和其他液體。 自動液體處理器可以最大限度地減少運行時間並最大限度地提高準確性。 此外，液體處理器能夠處理各種納升體積，證明了它們在分配任務中的實用性。
• 領先的公司不斷投資開發優質產品，為自動液體處理器開發樹立標桿，並有效提高生產力。 能夠處理微量液體的液體處理器的發展促進了市場上模塊化實驗室自動化系統的快速發展。
• 根據機器人行業協會的數據，自動液體處理機、自動板處理機和機械臂等工業機器人是生命科學領域增長第三快的部分，滿足了需求。
• Parker 表示，生命科學領域的機器人趨勢之一是簡化機器人分析儀中的流體學。 這種趨勢源於這樣一個事實，即臨床實驗室和醫院在處理關鍵樣本時不能停止設備。 機器人系統過去在移液裝置的尖端有 50 根針頭並使用許多管子，最近使用了一種特殊的閥組，無需管子並減少了故障的可能性。我來了。 該歧管基本上將洩漏的可能性降至最低。

北美市場份額最大

• 北美長期以來一直是臨床研究的先驅。 該地區是輝瑞、諾華、葛蘭素史克、強生和諾華等主要製藥公司的所在地。 該地區還擁有最集中的合同研究組織 (CRO)。 重要的 CRO 包括 Laboratory Corp. of America Holdings、IQVIA、Syneos Health 和 Parexel International Corp。 行業巨頭的存在和嚴格的 FDA 法規使該地區的市場競爭激烈。 為了在競爭中獲得優勢，該地區的基因組研究機構越來越多地在他們的實驗室中採用機器人技術和自動化技術。
• 尤其是在美國，基因組學行業仍在增長，預計在未來幾年內還會增長。 新基因組測序技術的可用性、完善的醫療保健基礎設施和不斷增長的老年人口是收入增長的主要驅動力。 在美國，由於增長和對效率的需求，血液中心引入了全自動無人值守系統來執行類型測試、篩查和傳染病測試。
• 許多公司都因其廣泛的研發能力而致力於創新。 例如，2021 年 8 月，禮來公司將與 Zias 合作，在聖地亞哥開設一個全自動禮來生命科學工作室實驗室。 自動化的各個領域可以包括純化、蛋白質工程、化合物合成、生物測試和分析，在這個實驗室使用 MagnaMotion Track。

蛋白質工程市場實驗室自動化競爭對手分析

由於大大小小的參與者將其產品出口到許多國家，蛋白質工程市場的實驗室自動化具有一定的競爭力。 主要參與者採用的主要策略是開發、合作夥伴關係和併購方面的技術進步。 主要參與者包括 Thermo Fisher Scientific Inc.、F. Hoffmann-La Roche Ltd、Siemens Healthineers、Danaher Corporation 和 PerkinElmer。 該市場的最新發展包括：

• 2021 年 11 月 - PKeye Workflow Monitor 是 PerkinElmer 基於雲的工具，使實驗室工作人員能夠實時遠程管理和監控 PerkinElmer 儀器和流程。 PKeye Workflow Monitor 使科學家和研究人員能夠訪問和了解實驗室流程。
• 2021 年 3 月 - 安捷倫科技公司宣布推出 MassHunter BioConfirm、MassHunter Networked Workstation 11.0 和 MassHunter Workstation Plus 11.0。 此外，安捷倫還發布了 VWorks 14.0 Plus，為其自動化液體處理平台增加了合規性功能。

其他福利。

• Excel 格式的市場預測 (ME) 表
• 3 個月的分析師支持

內容

第一章介紹

• 研究假設和市場定義
• 調查範圍

第二章研究方法論

第 3 章執行摘要

第 4 章市場洞察

• 市場概覽
• 價值鏈/供應鏈分析
• 產業吸引力 - 波特五力分析
  • 新進入者的威脅
  • 買家的議價能力
  • 供應商的議價能力
  • 替代品的威脅
  • 競爭公司之間的敵對關係
• 評估 COVID-19 對行業的影響

第 5 章市場動態

• 市場驅動力
  • 通過物聯網實現實驗室數字化轉型的趨勢不斷增強
  • 高效管理大量數據
• 市場製約因素
  • 昂貴的初始設置

第 6 章市場細分

• 按設備
  • 自動液體處理器
  • 自動印版機
  • 機械臂
  • 自動存儲和恢復系統 (AS/RS)
  • 其他設備
• 按地區
  • 北美
  • 歐洲
  • 亞太地區
  • 世界其他地方

第七章競爭格局

• 公司簡介
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation/Beckman Coulter
  • Hudson Robotics Inc.
  • Becton, Dickinson and Company
  • Synchron Lab Automation
  • Agilent Technologies Inc.
  • Siemens Healthineers AG
  • Tecan Group Ltd
  • Perkinelmer Inc.
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd

第八章投資分析

第九章市場機會與未來趨勢

The lab automation in protein engineering market is expected to register a CAGR of 12.4% over the forecast period (2022-2027). Protein engineering automation can aid scientists in deciphering and solving the mysteries of protein malfunction, such as misfolding, aggregation, and unusual movement. As a result, more effective medication discovery will be possible. One of the primary drivers for automation in the protein engineering industry is the fast-expanding demand for protein medications over non-protein pharmaceuticals and the increased prevalence of lifestyle disorders.

Key Highlights

• Protein-energy malnutrition (PEM) is rising in emerging economies' rural communities. It refers to a collection of illnesses that includes kwashiorkor, marasmus, and marasmus-kwashiorkor transitional phases. As a result, the incidence of kwashiorkor varies by region. It is quite uncommon in the United States. Central America, Southeast Asia, Congo, Jamaica, Puerto Rico, and South Africa are impacted. As a result, the rising frequency of protein-deficiency illnesses boosts total market demand.
• The healthcare business has been affected by a growing number of government efforts, such as sponsoring R&D for protein engineering and awareness programs. As a result, the government is funding several research initiatives ahead of time. For example, Protein Technologies Ltd (PTL) obtained money from the UK government's Technology Strategy Board (now Innovate UK) for their ground-breaking protein engineering research.
• Protein engineering also has a lot of potential in the agrochemical business because it can lead to better-functioning enzymes, boosting crop yields, or making biofuel production easier. It is also anticipated to play a vital role as a technique for achieving the higher agricultural yields required to satisfy future needs.
• Since the outbreak of COVID-19, labs have been turning their premises and resources into COVID-19 testing facilities, increasing automation equipment use. The University of Washington's laboratories were the first to do so. The statement came after the Broad Institute announced that its clinical processing lab would be converted into a large-scale COVID-19 testing facility.

Lab Automation in Protein Engineering Market Trends

Automated Liquid Handler Equipment Accounted for the Largest Market Share

• Liquid handlers are usually employed in biochemical and chemical laboratories. Automated liquid handling robots help in dispensing samples and other liquids in laboratories. Automated liquid handlers minimize run times and maximize accuracy. Moreover, liquid handlers are capable of operating across a wide range of volumes, extending into nanolitres, thus proving their usefulness in dispensing operations.
• Leading companies have set the benchmark for the development of automated liquid handlers and are constantly investing in developing premium products to increase productivity effectively. The evolution of the liquid handlers, capable of handling minute volumes of liquids, has contributed to the rapid development of modular lab automation systems in the market.
• According to the Robotic Industries Association, the life science sector has the third-highest growth in industrial robots, in terms of automated liquid handlers, automated plate handlers, robotic arms, and others, to meet the demand.
• According to Parker, one of the trends in life science robotics is fluidics getting simpler in robotic analyzers. This trend arose because clinical laboratories and hospitals cannot afford an instrument to go down when critical samples are involved. Certain robotic systems that used to have 50 needles on the end of a dispensing unit and lots of tubing increasingly use special valve manifolds that eliminate the need for tubing and result in less chance for failure. The manifolds basically minimize the chance of leakage.

North America Occupied the Largest Market Share

• North America has been a pioneer in clinical research for years. This region is home to major pharmaceutical companies, like Pfizer, Novartis, GlaxoSmithKline, J&J, and Novartis. The part also has the highest concentration of contract research organizations (CROs). Some of the significant CROs are Laboratory Corp. of America Holdings, IQVIA, Syneos Health, and Parexel International Corp. Owing to the presence of all the major players in the industry and stringent FDA regulations, the market is very competitive in the region. To gain an advantage over competitors, the genomics research organizations in the area are increasingly adopting robotics and automation in labs.
• The genomic industry, especially in the United States, is still growing and is expected to increase over the coming years. The availability of new genome sequencing technologies, well-established healthcare infrastructure, and the increasing geriatric population are significant contributing factors to revenue growth. In the United States, the need to accommodate growth and the drive to boost efficiency are priming blood centers to acquire fully automated walkaway systems to perform types and screens or test specimens for infectious diseases.
• Many companies are involved in innovation due to their extensive R&D capabilities. For instance, in August 2021, Eli Lilly and Company, in collaboration with Ziath, will open the completely automated Lilly Life Sciences Studio lab in San Diego. Individual areas of automation can encompass purification, protein engineering, compound synthesis, biological testing, and analysis in the lab, which is equipped with a Magnamotion track.

Lab Automation in Protein Engineering Market Competitor Analysis

The lab automation in protein engineering market is moderately competitive, owing to many small and big players exporting products to many countries. The key strategies adopted by the major players are technological advancement in development, partnerships, and merger and acquisition. Some of the major players in the market are Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Siemens Healthineers, Danaher Corporation, and PerkinElmer. Some of the recent developments in the market are:

• November 2021 - PKeye Workflow Monitor, a cloud-based tool from PerkinElmer, allowed lab employees to manage and monitor PerkinElmer instruments and processes in real-time remotely. The PKeye Workflow Monitor provides access to and visibility into laboratory processes for scientists and researchers.
• March 2021 - Agilent Technologies Inc. announced the launch of MassHunter BioConfirm, MassHunter Networked Workstation 11.0 and MassHunter Workstation Plus 11.0. In addition, Agilent also introduced VWorks 14.0 Plus, which adds compliance-enabling capabilities to the company's automated liquid handling platform.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 Study Assumptions and Market Definition
• 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET INSIGHTS

• 4.1 Market Overview
• 4.2 Value Chain/Supply Chain Analysis
• 4.3 Industry Attractiveness - Porter's Five Forces Analysis
  • 4.3.1 Threat of New Entrants
  • 4.3.2 Bargaining Power of Buyers
  • 4.3.3 Bargaining Power of Suppliers
  • 4.3.4 Threat of Substitute Products
  • 4.3.5 Intensity of Competitive Rivalry
• 4.4 Assessment of the COVID-19 Impact on the Industry

5 MARKET DYNAMICS

• 5.1 Market Drivers
  • 5.1.1 Growing Trend of Digital Transformation for Laboratories with IoT
  • 5.1.2 Effective Management of the Huge Amount of Data Generated
• 5.2 Market Restraints
  • 5.2.1 Expensive Initial Setup

6 MARKET SEGMENTATION

• 6.1 By Equipment
  • 6.1.1 Automated Liquid Handlers
  • 6.1.2 Automated Plate Handlers
  • 6.1.3 Robotic Arms
  • 6.1.4 Automated Storage and Retrieval Systems (AS/RS)
  • 6.1.5 Other Equipment
• 6.2 By Geography
  • 6.2.1 North America
  • 6.2.2 Europe
  • 6.2.3 Asia-Pacific
  • 6.2.4 Rest of the World

7 COMPETITIVE LANDSCAPE

• 7.1 Company Profiles
  • 7.1.1 Thermo Fisher Scientific Inc.
  • 7.1.2 Danaher Corporation/Beckman Coulter
  • 7.1.3 Hudson Robotics Inc.
  • 7.1.4 Becton, Dickinson and Company
  • 7.1.5 Synchron Lab Automation
  • 7.1.6 Agilent Technologies Inc.
  • 7.1.7 Siemens Healthineers AG
  • 7.1.8 Tecan Group Ltd
  • 7.1.9 Perkinelmer Inc.
  • 7.1.10 Eli Lilly and Company
  • 7.1.11 F. Hoffmann-La Roche Ltd

8 INVESTMENT ANALYSIS

9 MARKET OPPORTUNITIES AND FUTURE TRENDS